Glutamate-induced disruption of the blood-brain barrier in rats: Role of nitric oxide

Stroke

Volumn 27, Issue 5, 1996, Pages 965-970

  Mayhan, William G ^a   Didion, Sean P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

blood brain barrier; cerebral circulation; glutamate; nitric oxide; rats

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUTAMIC ACID; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; CONTROLLED STUDY; MALE; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0029879746     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.5.965     Document Type: Article

References (37)

1. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967;34:207-217.
2. Baethmann A, Maier-Hauff K, Kempski O, Unterberg A, Wahl M, Schurer L. Mediators of brain edema and secondary brain damage. Crit Care Med. 1988;16:972-978.
3. Westergren I, Nystrom B, Hamberger A, Nordborg C, Johansson BB. Concentrations of amino acids in extracellular fluid after opening of the blood-brain barrier by intracarotid infusion of protamine sulfate. J Neurochem. 1994;62:159-165.
4. Westergren I, Nordborg C, Johansson BB. Glutamate enhances brain damage and albumin content in cerebrospinal fluid after intracarotid protamine sulfate. Acta Neuropathol. 1993;85:285-290.
5. Westergren I, Johansson BB. NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema. Brain Res. 1992;573:324-326.
6. Ozyurt E, Graham DI, Woodruff GN, McCulloch J. Protective effect of the glutamate antagonist, MK-801, in focal cerebral ischemia in cats. J Cereb Blood Flow Metab. 1988;8:138-143.
7. Westergren I, Johansson BB. Blockade of AMPA receptors reduces brain edema following opening of the blood-brain barrier. J Cereb Blood Flow Metab. 1993;13:603-608.
8. Mayhan WG, Heistad DD. Permeability of blood-brain barrier to various sized molecules. Am J Physiol. 1985;248:H712-H718.
9. Mayhan WG, Faraci FM, Heistad DD. Disruption of the blood-brain barrier in cerebrum and brain stem during acute hypertension. Am J Physiol. 1986;251:H1171-H1175.
10. Mayhan WG, Heistad DD. Role of veins and cerebral venous pressure in disruption of the blood-brain barrier. Circ Res. 1986;59:216-220.
11. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319-1330.
12. Zhang J, Benveniste H, Klitzman B, Piantadosi CA. Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion. Stroke. 1995;26:298-304.
13. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs microcirculation. Am J Physiol. 1991;261:H1038-H1042.
14. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol. 1991;260:H319-H326.
15. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res. 1992;29:353-358.
16. Mayhan WG. Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. Brain Res. 1995;686:99-103.
17. 4-induced increases in microvascular transport. Am J Physiol. 1993;265:H409-H414.
18. Mayhan WG. Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol. 1994;266:H2369-H2373.
19. Mayhan WG. Role of nitric oxide in modulating permeability of the hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation. 1992;16:295-305.
20. Koenig HM, Pelligrino DA, Wang Q, Albrecht RF. Role of nitric oxide and endothelium in rat pial vessel dilation response to isoflurane. Anesth Analg. 1994;79:886-891.
21. 2 in vivo. J Cereb Blood Flow Metab. 1994;14:944-951.
22. Wang ZY, Hakanson R. Role of nitric oxide (NO) in ocular inflammation. Br J Pharmacol. 1995;116:2447-2450.
23. Miller FN, Joshua IG, Anderson GL. Quantitation of vasodilator-induced macromolecular leakage by in vivo fluorescent microscopy. Microvasc Res. 1982;24:56-67.
24. Meyer DJ, Huxley VH. Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators. Circ Res. 1992;70:382-391.
25. Chander CL, Moore AR, Desa FM, Howat D, Willoughby DA. The local modulation of vascular permeability by endothelial cell derived products. J Pharm Pharmacol. 1988;40:745-746.
26. Johansson B. Blood-brain barrier dysfunction in acute arterial hypertension after papaverine-induced vasodilatation. Acta Neurol Scand. 1974;50:573-580.
27. Nagy Z, Szabo M, Huttner I. Blood-brain barrier impairment by low pH buffer perfusion via the internal carotid artery in rat. Acta Neuropathol (Berl). 1985;68:160-163.
28. Baumbach GL, Heistad DD. Heterogeneity of brain blood flow and permeability during acute hypertension. Am J Physiol. 1985;249:H629-H637.
29. Mayhan WG, Faraci FM, Heistad DD. Effects of vasodilatation and acidosis on the blood-brain barrier. Microvasc Res. 1988;35:179-192.
30. Findling A, Schilling L, Bultmann A, Wahl M. Computerised image analysis in conjunction with fluorescence microscopy for the study of blood-brain barrier permeability in vivo. Pflugers Arch. 1994;427:86-95.
31. Meng W, Tobin JR, Busija DW. Glutamate-induced cerebral vasodilation is mediated by nitric oxide through N-methyl-D-aspartate receptors. Stroke. 1995;26:857-863.
32. Faraci FM, Breese KR, Heistad DD. Responses of cerebral arterioles to kainate. Stroke. 1994;25:2080-2084.
33. Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res. 1993;72:476-480.
34. Hardebo JE, Wieloch T, Kahrstrom J. Excitatory amino acids and cerebrovascular tone. Acta Physiol Scand. 1989;136:483-485.
35. Faraci FM, Brian JE. 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-D-aspartate. Stroke. 1995;26:2172-2176.
36. Dietrich WD, Alonso O, Halley M, Busto R, Globus MY-T. Intraventricular infusion of N-methyl-D-aspartate, I: acute blood-brain barrier consequences. Acta Neuropathol (Berl). 1992;84:621-629.
37. Koenig H, Trout JJ, Goldstone AD, Lu CY. Capillary NMDA receptors regulate blood-brain barrier function and breakdown. Brain Res. 1992;588:297-303.